GE Healthcare AS

本文数据来自于CPM新药研发监测数据库（cpm.pharmadl.com）。皮肤科用药2022年NMPA批准的进口皮肤科用药，共计10个（按照注册证号分类），获批品种较多的企业有艾伯维（3个）、诺华（3个）、香港澳美制药厂（3个）；涉及靶点排名前三的是FGFR3（3个）、IL17A（3个）、VDR（2个）。在政策相关度方面，2022年获批的进口皮肤科用药中，2022国家医保目录品种共有9个，没有带量采购招标品种。抗变态反应药物2022年NMPA批准的进口抗变态反应用药，共计10个（按照注册证号分类），获批品种较多的企业有Sun Pharmaceutical Industries Ltd（4个）、Therabel Healthcare Ltd（2个）、UCB Pharma AG（2个）；涉及靶点最多的的是HRH1（9个）。在政策相关度方面，2022年获批的进口抗变态反应用药中，2022国家医保目录品种共有5个，没有带量采购招标品种。杂类2022年NMPA批准的进口杂类用药，共计33个（按照注册证号分类），获批品种较多的企业有拜耳（14个）、GE Healthcare AS（6个）。在政策相关度方面，2022年获批的进口杂类用药中，2022国家医保目录品种共有29个，没有带量采购招标品种。中药2022年NMPA批准的进口中药用药，共计9个（按照注册证号分类），获批品种较多的企业有五塔药房有限公司（2个）、香港欧化药业有限公司（2个。在政策相关度方面，2022年获批的进口中药用药中，没有2022国家医保目录品种，没有带量采购招标品种。年度发布2023年《全球药研新动态》《中国医院市场用药格局》（2023版）2023年《数图药讯》权威发布2021年度中国医药工业百强榜单解读中国仿制药发展报告（2022版）医药行业专项报告中国医药中间体和原料药行业调研报告中国非甾体抗炎类原料药市场调研报告中国祛痰类原料药市场调研报告中国钙拮抗剂类原料药市场调研报告中国血管紧张素Ⅱ受体拮抗剂类原料药市场调研报告中国口服血糖调节类原料药市场调研报告中国中枢兴奋类原料药市场调研报告中国抗痛风类原料药市场调研报告中国脑血管病类原料药市场调研报告END如需获取更多数据洞察信息或公众号内容合作，请联系医药地理小助手微信号：pharmadl001

GE HealthCare has a vision for how it wants to shape the future of ultrasounds. The company wants ultrasound technology to be “used by nearly every clinician in nearly every situation in nearly every country around the world,” Karley Yoder, chief digital officer of GE HealthCare’s ultrasound division, said in an interview. Last week, GE HealthCare announced a deal that Yoder thinks will bring the company closer to achieving that vision. The firm unveiled its plan to acquire Caption Health, a company that sells AI software designed to guide cardiac imaging. San Mateo, California-based Caption was founded in 2013. The Food and Drug Administration cleared the company’s software, called Caption Guidance, in 2020. The agency said the clearance marked the first software ever authorized to guide users through cardiac ultrasound image acquisition. Caption’s guidance technology — which the FDA has cleared only for use in cardiac ultrasounds —aims to make ultrasound exams easier and faster, as well as allow a broader set of healthcare professionals to conduct basic echocardiography exams. It’s helpful to think of Caption’s technology like Apple Maps for ultrasound novices, said CEO Steve Cashman. The software enables non-experts to capture images and videos of diagnostic quality by emulating the guidance of an experienced sonographer. The technology communicates instructions via prompts on a screen-based interface — these prompts help users throughout the ultrasound process, such as guiding them on where they need to move the ultrasound probe or telling them how they can adjust controls on the device. This allows more medical professionals to quickly conduct cardiac ultrasounds, which could lead to the earlier detection of heart disease. “This technology allows novice users, as well as expert users, to be able to get to the right image in less time with higher confidence. And that’s really a paradigm shift in ultrasound, especially in the space of point-of-care ultrasound. It’s extremely important for folks who don’t use ultrasound nonstop everyday to have confidence that they can use this device,” Yoder said. There are multiple applications of AI, including AI-powered medical devices, cleared by the FDA to guide their users. For example, Eko earned FDA clearance for AI helps clinicians better detect heart murmurs and atrial fibrillation, and Cognita Labs won clearance for a smart cap that patients can put over their asthma inhalers to guide proper use. Caption’s technology is unique because it’s the first to assist in the acquisition of cardiac ultrasound images — good quality images are key to better diagnostic and even clinical outcomes. The healthcare system deals with heart failure in a “very reactive way” because patients need an ultrasound image in order to be diagnosed, Cashman pointed out. By democratizing the use of ultrasound imaging so it is not limited to people with technical expertise alone, more patients with heart failure can get diagnosed promptly — and therefore get started with their care plans — sooner. “Today we do breast cancer screening and colon cancer screening for earlier detection, but the leading cause of death in the world — heart disease and heart failure — is a reactive business.” Cashman declared. “By lowering the barrier to acquire the data that’s needed and a picture of the heart, we actually can do this more routinely in early care for patients that are at risk.” Lowering this barrier is especially important considering that there are only about 70,000 sonographers working in the U.S. — patients usually have to wait weeks to schedule an echocardiography exam with a sonographer, Cashman pointed out. Knowing how deadly heart disease can be, it’s imperative that the process of obtaining this image gets sped up, he said. Though GE The deal’s financial terms are not being disclosed, but GE HealthCare said it intends to fund the transaction with cash on hand. GE HealthCare looked at other companies in the point-of-care ultrasound AI space, but Yoder declined to name any. She said what really stood out about Caption is that it was the first in the field to build this AI guidance technology for echocardiograms and obtain FDA clearance for it. GE Healthcare also spoke with Caption’s customers, and Yoder said there was “real excitement about what the technology meant for their workflows and for their users.” In the future, Caption hopes to expand beyond the echocardiogram use case and into other kinds of ultrasound images, Cashman said. 内容来源于网络，如有侵权，请联系删除。

CHICAGO, Jan. 17, 2023 /PRNewswire/ -- According to Arizton's latest research report, the global wearable ECG devices market will grow at a CAGR of 19.32% during 2021-2027. The growth of the global wearable ECG devices market is anticipated to be driven by the growing adoption of cutting-edge sensors and AI-based wearable ECG devices with widely accessible clinical data. Additionally, vendors' increased emphasis on inorganic growth strategies is probably going to lead to significant product innovations, which will favorably impact the market development of wearable ECG devices globally. Continue Reading Wearable ECG Devices Market The global wearable ECG devices market is expected to grow significantly during the forecast period due to growing technological advancements, new product launches & approvals, and the rising adoption of smart wearables by the young generation. An increase in the incidence of CVDs has led to a growing volume of diagnosis across the globe. As the demand for continuous monitoring among patients is increasing, vendors are coming up with new technologically advanced devices with higher diagnostic yields and user-friendly devices. Innovations are firmly rooted in everyday life, and consumers are beginning to use software and hardware to manage their health. The recent trend of smart wearable devices is gaining popularity across the globe. The adoption of the smart wearable is highly boosted due to the impact of COVID-19. A new era of consumer-centric health has begun, bringing great future benefits to preventing, diagnosing, and treating cardiovascular diseases. Currently, several challenges are hampering the spread of wearable technology in clinical practice. With further sensor and computer technology development, wearables will process more complex functions and become an integral part of cardiovascular medical practices. Global Wearable ECG Devices Market Report Scope Click Here to Download the Free Download Report Geographical Insights North America is a major revenue contributor and accounts for 34.08% share of the global wearable ECG devices market. The region is the fastest-growing market for wearable ECG devices. North America offers tremendous opportunities for the players to boom in the market. The presence of a large pool of patients with atrial fibrillation requiring cardiac monitoring devices, higher acceptance of advanced and innovative wearable ECG devices, and high awareness toward the availability of advanced treatment options using devices for AF and stroke have collectively supported North America's dominance in the global market. Moreover, the region is the single largest market for wearable ECG devices, thus becoming strategically important to many prominent market players such as GE Healthcare, Koninklijke Philips, and others. For instance, GE Healthcare offers SEER 1000, SEER 12 Digital Holter ECG Recorder. Koninklijke Philips offers Holter Monitoring DigiTrak XT Holter System and Holter Monitoring Software. The Holter Monitoring DigiTrak XT Holter System is a sleek, streamlined recorder that is intended for patient comfort and streamlined workflows for all users. In addition, the Holter Monitoring Software can record, analyze, diagnose, and communicate ECG data quickly and accurately. Vendor Insights There are many emerging companies trying to compete in the patch-based wearable ECG devices market segment. Large medical device companies are adopting an acquisition strategy to invest or partner with many emerging vendors to diversify their product portfolio and strengthen their presence in the overall wearable ECG devices market. For instance, Philips acquired BioTelemetry, a leading vendor in the mobile cardiac telemetry segment, in February 2021. Similarly, Boston Scientific acquired Preventice Solutions in January 2021. This acquisition is likely to strengthen Boston Scientific, especially in the ambulatory wearable ECG device segment. Baxter International acquired Hill-Rom Services in December 2021. In May 2014, Medtronic acquired Corventis, focusing on the development of wireless cardiac monitoring patches. ECG-Based Smartwatches: Key Company Profiles Apple Alphabet Samsung Electronics Withings Other Wearable ECG Devices: Key Company Profiles Boston Scientific GE Healthcare iRhythm Technologies Hill-Rom Koninklijke Philips OSI Systems Other Prominent Vendors BPL Medical Technologies Bardy Diagnostics Bittium CardiacSense Cortrium FUKUDA DENSHI Masimo Medicalgorithmics Advanced Instrumentations AMEDTEC MEDIZINTECHNIK AUE ASPEL Hangzhou Beneware Medical Equipment Biotricity Borsam Biomedical Instruments BTL Contec Medical System Custo Med Oy Diagnostic Devices Development – DDD DMS-Service EB-Neuro Edan Instruments Forest Medical Holter Supplies Labtech LPU Medical LIVEWELL Lumed medical ECONET Medicomp Meditech KFT Meditech Equipment Midmark Monitor Nasan Medical Electronics Nasiff Associates Neurosoft Norav Medical Northeast Monitoring Recorders & Medicare Systems Scottcare Cardiovascular Solutions Schiller Shenzhen Biocare Bio-Medical Equipment Suzuken Company Trimpeks UPOLife VivaLNK Market Segmentation Product Smartwatch-Based ECG Mobile Cardiac Telemetry Holter Monitoring Cardiac Event Monitoring Frequency Episodic & Adhoc Continuous Geography APAC China India Japan South Korea Australia Europe Germany Italy Spain France UK North America US Canada Latin America Brazil Mexico Argentina Middle East & Africa Turkey South Africa South Arabia Check Out Some of the Top-Selling Related Research Reports: Remote Patient Monitoring Market - The global remote patient monitoring market is expected to reach USD 62 billion by 2027. Cardiac Monitoring Market - The global cardiac monitoring market is expected to reach USD 11.91 billion by 2027. Vital Signs Monitoring Devices Market - The global vital signs monitoring devices market size to cross USD 15 billion by 2025. Cardiac Assist Devices Market - The cardiac assist devices market size to reach USD 2.4 billion by 2025. Table of Content 1 RESEARCH METHODOLOGY 2 RESEARCH OBJECTIVES 3 RESEARCH PROCESS 4 SCOPE & COVERAGE 4.1 MARKET DEFINITION 4.1.1 INCLUSIONS 4.1.2 EXCLUSIONS 4.1.3 MARKET ESTIMATION CAVEATS 4.2 BASE YEAR 4.3 SCOPE OF THE STUDY 4.3.1 MARKET SEGMENTATION BY GEOGRAPHY 5 REPORT ASSUMPTIONS & CAVEATS 5.1 KEY CAVEATS 5.2 CURRENCY CONVERSION 5.3 MARKET DERIVATION 6 MARKET AT A GLANCE 7 INTRODUCTION 7.1 OVERVIEW 7.1.1 WEARABLE ECG DEVICES 8 PREMIUM INSIGHTS 8.1 MARKET SCENARIO 8.1.1 OVERVIEW 8.1.2 MARKET SEGMENTATION 9 MARKET OPPORTUNITIES & TRENDS 9.1 INCREASING USE OF ADVANCED SENSORS & AI IN WEARABLE ECG DEVICES 9.2 EMERGENCE OF SMARTWATCHES EQUIPPED WITH ECG 9.3 NEW PRODUCT APPROVALS & LAUNCHES IN WEARABLE ECG DEVICES 9.4 GROWING POPULARITY OF SMART WEARABLE TECHNOLOGY IN ECG 10 MARKET GROWTH ENABLERS 10.1 INCREASING GLOBAL PREVALENCE OF CARDIOVASCULAR DISEASES 10.2 PARADIGM SHIFT FROM CONVENTIONAL ECG TOWARD AMBULATORY ECG 10.3 HIGH DEMAND FOR MCT & NEXT-GENERATION HOLTER MONITORS 11 MARKET GROWTH RESTRAINTS 11.1 LIMITATIONS & RISKS ASSOCIATED WITH WEARABLE ECG DEVICES 11.2 HIGH COST OF WEARABLE ECG DEVICES 11.3 AVAILABILITY OF ALTERNATE CARDIAC MONITORING DEVICES 12 MARKET LANDSCAPE 12.1 MARKET OVERVIEW 12.2 MARKET SIZE & FORECAST 12.2.1 GEOGRAPHY INSIGHTS 12.2.2 PRODUCT INSIGHTS 12.2.3 FREQUENCY INSIGHTS 12.3 FIVE FORCES ANALYSIS 12.3.1 THREAT OF NEW ENTRANTS 12.3.2 BARGAINING POWER OF SUPPLIERS 12.3.3 BARGAINING POWER OF BUYERS 12.3.4 THREAT OF SUBSTITUTES 12.3.5 COMPETITIVE RIVALRY 13 PRODUCT 13.1 MARKET SNAPSHOT & GROWTH ENGINE 13.2 MARKET OVERVIEW 13.3 SMARTWATCH-BASED ECG 13.3.1 MARKET OVERVIEW 13.3.2 MARKET SIZE & FORECAST 13.3.3 MARKET BY GEOGRAPHY 13.4 MOBILE CARDIAC TELEMETRY 13.4.1 MARKET OVERVIEW 13.4.2 MARKET SIZE & FORECAST 13.4.3 MARKET BY GEOGRAPHY 13.5 HOLTER MONITORING 13.5.1 MARKET OVERVIEW 13.5.2 MARKET SIZE & FORECAST 13.5.3 MARKET BY GEOGRAPHY 13.6 CARDIAC EVENT MONITORING 13.6.1 MARKET OVERVIEW 13.6.2 MARKET SIZE & FORECAST 13.6.3 MARKET BY GEOGRAPHY 14 FREQUENCY 14.1 MARKET SNAPSHOT & GROWTH ENGINE 14.2 MARKET OVERVIEW 14.3 EPISODIC & ADHOC 14.3.1 MARKET OVERVIEW 14.3.2 MARKET SIZE & FORECAST 14.3.3 MARKET BY GEOGRAPHY 14.4 CONTINUOUS 14.4.1 MARKET OVERVIEW 14.4.2 MARKET SIZE & FORECAST 14.4.3 MARKET BY GEOGRAPHY 15 GEOGRAPHY 15.1 MARKET SNAPSHOT & GROWTH ENGINE 15.2 GEOGRAPHIC OVERVIEW 16 NORTH AMERICA 16.1 MARKET OVERVIEW 16.1.1 MARKET SIZE & FORECAST 16.1.2 NORTH AMERICA: PRODUCT SEGMENTATION 16.1.3 NORTH AMERICA: FREQUENCY SEGMENTATION 16.2 KEY COUNTRIES 16.2.1 US: MARKET SIZE & FORECAST 16.2.2 CANADA: MARKET SIZE & FORECAST 17 EUROPE 17.1 MARKET OVERVIEW 17.1.1 MARKET SIZE & FORECAST 17.1.2 EUROPE: PRODUCT SEGMENTATION 17.1.3 EUROPE: FREQUENCY SEGMENTATION 17.2 KEY COUNTRIES 17.2.1 GERMANY: MARKET SIZE & FORECAST 17.2.2 FRANCE: MARKET SIZE & FORECAST 17.2.3 UK: MARKET SIZE & FORECAST 17.2.4 ITALY: MARKET SIZE & FORECAST 17.2.5 SPAIN: MARKET SIZE & FORECAST 18 APAC 18.1 MARKET OVERVIEW 18.1.1 MARKET SIZE & FORECAST 18.1.2 APAC: PRODUCT SEGMENTATION 18.1.3 APAC: FREQUENCY SEGMENTATION 18.2 KEY COUNTRIES 18.2.1 JAPAN: MARKET SIZE & FORECAST 18.2.2 CHINA: MARKET SIZE & FORECAST 18.2.3 INDIA: MARKET SIZE & FORECAST 18.2.4 SOUTH KOREA: MARKET SIZE & FORECAST 18.2.5 AUSTRALIA: MARKET SIZE & FORECAST 19 LATIN AMERICA 19.1 MARKET OVERVIEW 19.1.1 MARKET SIZE & FORECAST 19.1.2 LATIN AMERICA: PRODUCT SEGMENTATION 19.1.3 LATIN AMERICA: FREQUENCY SEGMENTATION 19.2 KEY COUNTRIES 19.2.1 BRAZIL: MARKET SIZE & FORECAST 19.2.2 MEXICO: MARKET SIZE & FORECAST 19.2.3 ARGENTINA: MARKET SIZE & FORECAST 20 MIDDLE EAST & AFRICA 20.1 MARKET OVERVIEW 20.1.1 MARKET SIZE & FORECAST 20.1.2 MIDDLE EAST & AFRICA: PRODUCT SEGMENTATION 20.1.3 MIDDLE EAST & AFRICA: FREQUENCY SEGMENTATION 20.2 KEY COUNTRIES 20.2.1 TURKEY: MARKET SIZE & FORECAST 20.2.2 SAUDI ARABIA: MARKET SIZE & FORECAST 20.2.3 SOUTH AFRICA: MARKET SIZE & FORECAST 21 COMPETITIVE LANDSCAPE 21.1 COMPETITION OVERVIEW 21.2 MARKET SHARE ANALYSIS 22 ECG-BASED SMARTWATCHES: KEY COMPANY PROFILES 22.1 APPLE 22.1.1 BUSINESS OVERVIEW 22.1.2 APPLE IN WEARABLE ECG DEVICES MARKET 22.1.3 PRODUCT OFFERINGS 22.1.4 KEY STRATEGIES 22.1.5 KEY STRENGTHS 22.1.6 KEY OPPORTUNITIES 22.2 ALPHABET 22.2.1 BUSINESS OVERVIEW 22.2.2 ALPHABET IN WEARABLE ECG DEVICES MARKET 22.2.3 PRODUCT OFFERINGS 22.2.4 KEY STRATEGIES 22.2.5 KEY STRENGTHS 22.2.6 KEY OPPORTUNITIES 22.3 SAMSUNG ELECTRONICS 22.3.1 BUSINESS OVERVIEW 22.3.2 SAMSUNG ELECTRONICS IN WEARABLE ECG DEVICES MARKET 22.3.3 PRODUCT OFFERINGS 22.3.4 KEY STRATEGIES 22.3.5 KEY STRENGTHS 22.3.6 KEY OPPORTUNITIES 22.4 WITHINGS 22.4.1 BUSINESS OVERVIEW 22.4.2 WITHINGS IN WEARABLE ECG DEVICES MARKET 22.4.3 PRODUCT OFFERINGS 22.4.4 KEY STRATEGIES 22.4.5 KEY STRENGTHS 22.4.6 KEY OPPORTUNITIES 23 OTHER WEARABLE ECG DEVICES: KEY COMPANY PROFILES 23.1 BOSTON SCIENTIFIC 23.1.1 BUSINESS OVERVIEW 23.1.2 BOSTON SCIENTIFIC IN WEARABLE ECG DEVICES MARKET 23.1.3 PRODUCT OFFERINGS 23.1.4 KEY STRATEGIES 23.1.5 KEY STRENGTHS 23.1.6 KEY OPPORTUNITIES 23.2 GE HEALTHCARE 23.2.1 BUSINESS OVERVIEW 23.2.2 GE HEALTHCARE IN WEARABLE ECG DEVICES MARKET 23.2.3 PRODUCT OFFERINGS 23.2.4 KEY STRATEGIES 23.2.5 KEY STRENGTHS 23.2.6 KEY OPPORTUNITIES 23.3 IRHYTHM TECHNOLOGIES 23.3.1 BUSINESS OVERVIEW 23.3.2 IRHYTHM TECHNOLOGIES IN WEARABLE ECG DEVICES MARKET 23.3.3 PRODUCT OFFERINGS 23.3.4 KEY STRATEGIES 23.3.5 KEY STRENGTHS 23.3.6 KEY OPPORTUNITIES 23.4 HILL-ROM 23.4.1 BUSINESS OVERVIEW 23.4.2 HILL-ROM IN WEARABLE ECG DEVICES MARKET 23.4.3 PRODUCT OFFERINGS 23.4.4 KEY STRATEGIES 23.4.5 KEY STRENGTHS 23.4.6 KEY OPPORTUNITIES 23.5 KONINKLIJKE PHILIPS 23.5.1 BUSINESS OVERVIEW 23.5.2 KONINKLIJKE PHILIPS IN WEARABLE ECG DEVICES MARKET 23.5.3 PRODUCT OFFERINGS 23.5.4 KEY STRATEGIES 23.5.5 KEY STRENGTHS 23.5.6 KEY OPPORTUNITIES 23.6 OSI SYSTEMS 23.6.1 BUSINESS OVERVIEW 23.6.2 OSI SYSTEMS IN WEARABLE ECG DEVICES MARKET 23.6.3 PRODUCT OFFERINGS 23.6.4 KEY STRATEGIES 23.6.5 KEY STRENGTHS 23.6.6 KEY OPPORTUNITIES 24 OTHER PROMINENT VENDORS 24.1 AEROTEL MEDICAL SYSTEMS 24.1.1 BUSINESS OVERVIEW 24.1.2 PRODUCT OFFERINGS 24.2 ADVANCED INSTRUMENTATIONS 24.2.1 BUSINESS OVERVIEW 24.2.2 PRODUCT OFFERINGS 24.3 AMEDTEC MEDIZINTECHNIK AUE 24.3.1 BUSINESS OVERVIEW 24.3.2 PRODUCT OFFERINGS 24.4 ASPEL 24.4.1 BUSINESS OVERVIEW 24.4.2 PRODUCT OFFERINGS 24.5 BPL MEDICAL TECHNOLOGIES 24.5.1 BUSINESS OVERVIEW 24.5.2 PRODUCT OFFERINGS 24.6 BARDY DIAGNOSTICS 24.6.1 BUSINESS OVERVIEW 24.6.2 PRODUCT OFFERINGS 24.7 BITTIUM 24.7.1 BUSINESS OVERVIEW 24.7.2 PRODUCT OFFERINGS 24.8 BIOTRICITY 24.8.1 BUSINESS OVERVIEW 24.8.2 PRODUCT OFFERINGS 24.9 BORSAM BIOMEDICAL INSTRUMENTS 24.9.1 BUSINESS OVERVIEW 24.9.2 PRODUCT OFFERINGS 24.10 BTL 24.10.1 BUSINESS OVERVIEW 24.10.2 PRODUCT OFFERINGS 24.11 CARDIACSENSE 24.11.1 BUSINESS OVERVIEW 24.11.2 PRODUCT OFFERINGS 24.12 CORTRIUM 24.12.1 BUSINESS OVERVIEW 24.12.2 PRODUCT OFFERINGS 24.13 CONTEC MEDICAL SYSTEMS 24.13.1 BUSINESS OVERVIEW 24.13.2 PRODUCT OFFERINGS 24.14 CUSTO MED 24.14.1 BUSINESS OVERVIEW 24.14.2 PRODUCT OFFERINGS 24.15 DMS-SERVICE 24.15.1 BUSINESS OVERVIEW 24.15.2 PRODUCT OFFERINGS 24.16 EB NEURO 24.16.1 BUSINESS OVERVIEW 24.16.2 PRODUCT OFFERINGS 24.17 EDAN INSTRUMENTS 24.17.1 BUSINESS OVERVIEW 24.17.2 PRODUCT OFFERINGS 24.18 FUKUDA DENSHI 24.18.1 BUSINESS OVERVIEW 24.18.2 PRODUCT OFFERINGS 24.19 FOREST MEDICAL 24.19.1 BUSINESS OVERVIEW 24.19.2 PRODUCT OFFERINGS 24.20 HANGZHOU BENEWARE MEDICAL EQUIPMENT 24.20.1 BUSINESS OVERVIEW 24.20.2 PRODUCT OFFERINGS 24.21 HOLTER SUPPLIES 24.21.1 BUSINESS OVERVIEW 24.21.2 PRODUCT OFFERINGS 24.22 LABTECH 24.22.1 BUSINESS OVERVIEW 24.22.2 PRODUCT OFFERINGS 24.23 LEPU MEDICAL TECHNOLOGY 24.23.1 PRODUCT OFFERINGS 24.24 LIVEWELL 24.24.1 BUSINESS OVERVIEW 24.24.2 PRODUCT OFFERINGS 24.25 LUMED 24.25.1 BUSINESS OVERVIEW 24.25.2 PRODUCT OFFERINGS 24.26 MASIMO 24.26.1 BUSINESS OVERVIEW 24.26.2 PRODUCT OFFERINGS 24.27 MEDICALGORITHMICS 24.27.1 BUSINESS OVERVIEW 24.27.2 PRODUCT OFFERINGS 24.28 MEDICAL ECONET 24.28.1 BUSINESS OVERVIEW 24.28.2 PRODUCT OFFERINGS 24.29 MEDICOMP 24.29.1 BUSINESS OVERVIEW 24.29.2 PRODUCT OFFERINGS 24.30 MEDITECH KFT 24.30.1 BUSINESS OVERVIEW 24.30.2 PRODUCT OFFERINGS 24.31 MEDITECH EQUIPMENT 24.31.1 BUSINESS OVERVIEW 24.31.2 PRODUCT OFFERINGS 24.32 MIDMARK 24.32.1 BUSINESS OVERVIEW 24.32.2 PRODUCT OFFERINGS 24.33 MONITOR 24.33.1 BUSINESS OVERVIEW 24.33.2 PRODUCT OFFERINGS 24.34 NASAN MEDICAL ELECTRONICS 24.34.1 BUSINESS OVERVIEW 24.34.2 PRODUCT OFFERINGS 24.35 NASIFF ASSOCIATES 24.35.1 BUSINESS OVERVIEW 24.35.2 PRODUCT OFFERINGS 24.36 NEUROSOFT 24.36.1 BUSINESS OVERVIEW 24.36.2 PRODUCT OFFERINGS 24.37 NORAV MEDICAL 24.37.1 BUSINESS OVERVIEW 24.37.2 PRODUCT OFFERINGS 24.38 NORTHEAST MONITORING 24.38.1 BUSINESS OVERVIEW 24.38.2 PRODUCT OFFERINGS 24.39 OY DIAGNOSTIC DEVICES DEVELOPMENT – DDD 24.39.1 BUSINESS OVERVIEW 24.39.2 PRODUCT OFFERINGS 24.40 RECORDERS & MEDICARE SYSTEMS 24.40.1 BUSINESS OVERVIEW 24.40.2 PRODUCT OFFERINGS 24.41 SCOTTCARE CARDIOVASCULAR SOLUTIONS 24.41.1 BUSINESS OVERVIEW 24.41.2 PRODUCT OFFERINGS 24.42 SCHILLER 24.42.1 BUSINESS OVERVIEW 24.42.2 PRODUCT OFFERINGS 24.43 SHENZHEN BIOCARE BIO-MEDICAL EQUIPMENT 24.43.1 BUSINESS OVERVIEW 24.43.2 PRODUCT OFFERINGS 24.44 SUZUKEN COMPANY 24.44.1 BUSINESS OVERVIEW 24.44.2 PRODUCT OFFERINGS 24.45 TRIMPEKS 24.45.1 BUSINESS OVERVIEW 24.45.2 PRODUCT OFFERINGS 24.46 UPOLIFE 24.46.1 BUSINESS OVERVIEW 24.46.2 PRODUCT OFFERINGS 24.47 VIVALNK 24.47.1 BUSINESS OVERVIEW 24.47.2 PRODUCT OFFERINGS 25 REPORT SUMMARY 25.1 KEY TAKEAWAYS 25.2 STRATEGIC RECOMMENDATIONS 26 QUANTITATIVE SUMMARY 26.1 MARKET BY PRODUCT 26.1.1 NORTH AMERICA: PRODUCT SEGMENTATION 26.1.2 EUROPE: PRODUCT SEGMENTATION 26.1.3 APAC: PRODUCT SEGMENTATION 26.1.4 LATIN AMERICA: PRODUCT SEGMENTATION 26.1.5 MIDDLE EAST & AFRICA: PRODUCT SEGMENTATION 26.2 MARKET BY FREQUENCY 26.2.1 NORTH AMERICA: FREQUENCY SEGMENTATION 26.2.2 EUROPE: FREQUENCY SEGMENTATION 26.2.3 APAC: FREQUENCY SEGMENTATION 26.2.4 LATIN AMERICA: FREQUENCY SEGMENTATION 26.2.5 MIDDLE EAST & AFRICA: FREQUENCY SEGMENTATION 26.3 MARKET BY GEOGRAPHY 26.3.1 SMARTWATCH-BASED ECG: GEOGRAPHY SEGMENTATION 26.3.2 MOBILE CARDIAC TELEMETRY: GEOGRAPHY SEGMENTATION 26.3.3 HOLTER MONITORING: GEOGRAPHY SEGMENTATION 26.3.4 CARDIAC EVENT MONITORING: GEOGRAPHY SEGMENTATION 26.3.5 EPISODIC & ADHOC: GEOGRAPHY SEGMENTATION 26.3.6 CONTINUOUS: GEOGRAPHY SEGMENTATION 27 APPENDIX 27.1 ABBREVIATIONS About Us :  Arizton Advisory and Intelligence is an innovative and quality-driven firm that offers cutting-edge research solutions to clients worldwide. We excel in providing comprehensive market intelligence reports and advisory and consulting services. We offer comprehensive market research reports on consumer goods & retail technology, automotive and mobility, smart tech, healthcare, life sciences, industrial machinery, chemicals, materials, I.T. and media, logistics, and packaging. These reports contain detailed industry analysis, market size, share, growth drivers, and trend forecasts.  Arizton comprises a team of exuberant and well-experienced analysts who have mastered generating incisive reports. Our specialist analysts possess exemplary skills in market research. We train our team in advanced research practices, techniques, and ethics to outperform in fabricating impregnable research reports.  Click Here to Contact Us Call: +1-312-235-2040 +1 302 469 0707 Mail: [email protected] Photo - Logo - SOURCE Arizton Advisory & Intelligence